Literature DB >> 11939833

Sarcoidosis during combined interferon alfa and ribavirin therapy in 2 patients with chronic hepatitis C.

Jeanne Wendling, Vincent Descamps, Maggy Grossin, Patrick Marcellin, Patrick Le Bozec, Stéphane Belaich, Béatrice Crickx.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11939833     DOI： 10.1001/archderm.138.4.546

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN： 0003-987X


× No keyword cloud information.
  4 in total

Review 1.  Development of sarcoidosis following completion of treatment for hepatitis C with pegylated interferon-{alpha}2a and ribavirin: a case report and literature review.

Authors:  Albéric-Rembrandt Gayet; Patrick Plaisance; Jean-François Bergmann; Stéphane Mouly
Journal:  Clin Med Res       Date:  2010-09-17

Review 2.  Management of adverse effects of Peg-IFN and ribavirin therapy for hepatitis C.

Authors:  Mark S Sulkowski; Curtis Cooper; Bela Hunyady; Jidong Jia; Pavel Ogurtsov; Markus Peck-Radosavljevic; Mitchell L Shiffman; Cihan Yurdaydin; Olav Dalgard
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-03-08       Impact factor: 46.802

3.  Subcutaneous Sarcoidosis during Pegylated Interferon Alfa and Ribavirin Treatment for Chronic Hepatitis C.

Authors:  R Rodríguez-Lojo; M Almagro; J M Barja; F Piñeyro; L Pérez-Varela; J Del Pozo; M T Yebra-Pimentel; E Fonseca
Journal:  Dermatol Res Pract       Date:  2010-04-29

4.  Pegylated Interferon-Induced Sarcoidosis Presenting With Anterior Uveitis in a Patient with Chronic Hepatitis C - Case Report.

Authors:  A M Kamal; P Mitruț; C K Kamal; D O Alexandru; A Tica
Journal:  Curr Health Sci J       Date:  2015-12-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.